Atlas Trials

Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia

Clinical trial NCT00913614 · COMPLETED

Trial details

NCT number
NCT00913614
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sleep Initiation and Maintenance Disorders
Start date
2009-06-01
Primary completion
2009-12-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.